Evidence map›Paper›PMID 42262305›Full record

ArticleBritish journal of haematology2026

Paediatric-onset autoimmune cytopenia: How can we reduce the long-term mortality?

Nathalie Aladjidi, Thierry Leblanc, Helder Fernandes, Capucine Picard, Jacinta Bustamante, Frédéric Rieux-Laucat, Mathieu Fusaro, Maud Tusseau, Charlotte Durand-Teyssier, Emma Cohendy and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Nathalie AladjidiCEREVANCE, CEREDIH, Pediatric Hemato-Immunology, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.
Thierry LeblancCEREVANCE, Pediatric Onco-Hematology, Robert Debré University Hospital, AP-HP, Paris, France.ORCID https://orcid.org/0000-0003-2463-9346
Helder FernandesCEREVANCE, CEREDIH, Pediatric Hemato-Immunology, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.
Capucine PicardStudy Center for Primary Immunodeficiencies, CEREDIH, Necker-Enfants Malades Hospital, AP-HP, University of Paris Cité, Paris, France.ORCID https://orcid.org/0000-0001-8788-5056
Jacinta BustamanteStudy Center for Primary Immunodeficiencies, CEREDIH, Necker-Enfants Malades Hospital, AP-HP, University of Paris Cité, Paris, France.
Frédéric Rieux-LaucatLaboratory of Human Genetics of Infectious Diseases, Inserm U1163, Imagine Institute, University of Paris Cité, Paris, France.ORCID https://orcid.org/0000-0001-7858-7866
Mathieu FusaroImmunology Department Laboratory, INFINITy, Toulouse Institute for Infectious and Inflammatory Diseases, INSERM, U1291, CNRS U5051, University Toulouse III, Toulouse, France.
Maud TusseauDepartment of Medical Genetics, Centre International de Recherche en Infectiologie, Inserm, U1111, CNRS, UMR5308, ENS de Lyon, University of Lyon, Lyon, France.
Charlotte Durand-TeyssierCEREVANCE, CEREDIH, Pediatric Hemato-Immunology, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.
Emma CohendyCEREVANCE, CEREDIH, Pediatric Hemato-Immunology, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.
Jérôme GranelCEREVANCE, CEREDIH, Pediatric Hemato-Immunology, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.ORCID https://orcid.org/0000-0002-4470-1023
Stéphane DucassouCEREVANCE, CEREDIH, Pediatric Hemato-Immunology, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.
Agathe EscudierCEREVANCE, CEREDIH, Pediatric Hemato-Immunology, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.
Despina MoshousPediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospital, APHP, Institut Imagine and Université Paris Cité, Paris, France.
Marc MichelDepartment of Internal Medicine, CERECAI, Créteil University Hospital, Créteil, France.
Bertrand GodeauDepartment of Internal Medicine, CERECAI, Créteil University Hospital, Créteil, France.
Sébastien HéritierCEREVANCE, Pediatric Onco-Hematology, Armand-Trousseau University Hospital, UMR-S398, Sorbonne University, Paris, France.
Mony FahdCEREVANCE, Pediatric Onco-Hematology, Robert Debré University Hospital, AP-HP, Paris, France.
Brigitte Bader-MeunierDepartment of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP, RAISE, Paris, France.
Alain FischerCollège de France, Paris, France.
Guy LevergerCEREVANCE, Pediatric Onco-Hematology, Armand-Trousseau University Hospital, UMR-S398, Sorbonne University, Paris, France.
All collaborators from the French Paediatric Haemato‐Immunologic CEREVANCE Network

Funding

Agence Nationale de la Recherche ANR-10-IAHU-01Agence Nationale de la Recherche ANR-14-CE14-0026-01Agence Nationale de la Recherche ANR-18-CE17-0001Agence Nationale de la Recherche ANR-18-RHUS-0010Agence Nationale de la Recherche ANR-21-CE17_00444Agence Nationale de la Recherche ANR-22-CE15-0047-02Fondation pour la Recherche Médicale EQU202103012670Fondation pour la Recherche Médicale EQU202503020056French Filière Maladies Rares Immuno Hématologiques (MARIH)French Ministry of HealthPatient and Médical Charities
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoimmune haemolytic anaemiachildrenEvans syndromeimmune thrombocytopenia

Identifiers

PMID42262305
PMCPMC13461972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.